1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PLK-1 inhibition has a functional impact on MYC and is a relevant target for high-risk mantle cell lymphoma patients
- Master (Two yrs)
- 2021
-
Mark
Drug-induced response and antibody-dependent cellular cytotoxicity in microfluidic cultures with dynamic flow
- Master (Two yrs)
-
Mark
Analysis of Myc Aberrations in Mantle Cell Lymphoma and Drug Target Identification
- Master (Two yrs)
-
Mark
DLBCL Patient stratification using serum protein profiling
- Master (Two yrs)
- 2020
-
Mark
Spatial Multiplex Analysis of Immune Cell Infiltration in Mantle Cell Lymphoma
- Master (Two yrs)
-
Mark
Serum protein profiling of B-cell lymphoma cohorts using the IMMRay microarray technology
- Master (Two yrs)
-
Mark
Microfluidic model for B-cell lymphoma
- Master (Two yrs)
- 2019
-
Mark
Molecular Investigations of Mantle Cell Lymphoma
- Master (Two yrs)
- 2017
-
Mark
Evaluation of CD44 and CD69 protein expression and pathway analysis of side population cells in mantle cell lymphoma
- Master (Two yrs)
-
Mark
Functional investigations of SPI-B and dCK in relation to cytarabine resistance in MCL
- Master (Two yrs)